Local delivery strategies using regulatory T cells and their extracellular vesicles for none repair

Bone repair requires a coordinated transition from inflammation to regeneration. Regulatory T cells (Tregs) participate in this transition through immune suppression, interactions with macrophages, and signals that support skeletal progenitors. Their extracellular vesicles (Treg-EVs) provide a complementary means of transferring selected regulatory activities without administering living cells. Recent studies have connected these biological mechanisms to local therapeutic platforms, including Treg-loaded fibrin hydrogels, materials that recruit endogenous Tregs, and injectable systems delivering Treg-EVs with progenitor-recruiting factors. This Mini Review examines these approaches while distinguishing fracture and bone-defect repair from ectopic osteogenesis and protection against inflammatory bone loss. We discuss how IL-10, amphiregulin, progranulin, and vesicular purinergic signaling inform delivery design, and why cellular mechanisms cannot automatically be assigned to EV preparations. Particular attention is given to therapeutic timing, material–immune interactions, cell identity, vesicle heterogeneity and potency, and causal evaluation.

Authors

Institutions

Publication Details

Journal
Frontiers in Bioengineering and Biotechnology
Published
2026-11-17
DOI
https://doi.org/10.3389/fbioe.2026.2008663
Primary Topic
Bone Tissue Engineering Materials
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Local delivery strategies using regulatory T cells and their extracellular vesicles for none repair

Zhi Zheng, Xinyan Wu, Zhichao Chen, Tingting Xu et al.
3 links
Frontiers in Bioengineering and Biotechnology
Bone Tissue Engineering Materials
article

Local delivery strategies using regulatory T cells and their extracellular vesicles for none repair

Zhi Zheng, Xinyan Wu, Zhichao Chen, Tingting Xu, Zhiwei Zhang
article en

Abstract

Bone repair requires a coordinated transition from inflammation to regeneration. Regulatory T cells (Tregs) participate in this transition through immune suppression, interactions with macrophages, and signals that support skeletal progenitors. Their extracellular vesicles (Treg-EVs) provide a complementary means of transferring selected regulatory activities without administering living cells. Recent studies have connected these biological mechanisms to local therapeutic platforms, including Treg-loaded fibrin hydrogels, materials that recruit endogenous Tregs, and injectable systems delivering Treg-EVs with progenitor-recruiting factors. This Mini Review examines these approaches while distinguishing fracture and bone-defect repair from ectopic osteogenesis and protection against inflammatory bone loss. We discuss how IL-10, amphiregulin, progranulin, and vesicular purinergic signaling inform delivery design, and why cellular mechanisms cannot automatically be assigned to EV preparations. Particular attention is given to therapeutic timing, material–immune interactions, cell identity, vesicle heterogeneity and potency, and causal evaluation.

Frontiers in Bioengineering and BiotechnologyVol. 14
Integrated Chinese Medicine (China) (HK), China Agricultural University (CN)
Good health and well-being
Bone Tissue Engineering Materials
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon